| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 10/03/2007 | EP1839659A2 Chemicals compounds |
| 10/03/2007 | EP1838703A2 Heteroaryl substituted piperazinyl-pyridine analogues |
| 10/03/2007 | EP1838701A1 N-substituted heterocyclic sulfonamides |
| 10/03/2007 | EP1838680A2 Macrocyclic compounds and compositions useful as bace inhibitors |
| 10/03/2007 | EP1838675A1 Novel 4-arylamino pyridone derivatives as mek inhibitors for the treatment of hyperproliferative disorders |
| 10/03/2007 | EP1838669A1 Indoles useful in the treatment of inflammation |
| 10/03/2007 | EP1838304A2 Heterocyclic aspartyl protease inhibitors |
| 10/03/2007 | EP1838296A2 Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases |
| 10/03/2007 | EP1737850B1 A novel process for the preparation of linezolid and related compounds |
| 10/03/2007 | EP1599468B1 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia |
| 10/03/2007 | EP1173421B1 Indole derivatives as anti-inflammation agents |
| 10/03/2007 | CN101048403A Heterocyclic antiviral compounds |
| 10/03/2007 | CN101048402A Carbazole derivative, solvate thereof, or pharmaceutically acceptable salt thereof |
| 10/03/2007 | CN101048397A 6-(pyridinyl)-4-pyrimidone derivates as tau protein kinase 1 inhibitors |
| 10/03/2007 | CN101048393A Substituted N-arylsulfonylheterocyclic amines as gamma-secretase inhibitors |
| 10/03/2007 | CN101048391A Tetracyclic indole derivatives as antiviral agents |
| 10/03/2007 | CN101048388A Quinazolinone derivatives and their use as B-Raf inhibitors |
| 10/03/2007 | CN101048386A 嘧啶衍生物 Pyrimidine derivatives |
| 10/03/2007 | CN101048383A 促性腺激素释放激素受体拮抗剂 Gonadotropin-releasing hormone receptor antagonist |
| 10/03/2007 | CN101048161A Arylthiobenzylpiperidine derivates |
| 10/03/2007 | CN100340548C Novel arylheteroalkylamine derivatives |
| 10/02/2007 | US7276612 For hepatitis C; histone deacetylase inhibitors; N-hydroxy-4-{[(benzofuran-, benzothiophen-, or indol-)-2-ylcarbonylamino]alkoxy}benzamides |
| 10/02/2007 | US7276608 3-(amino)sulfonylamino-substituted, e.g., N-(1,6-Dibenzyl-2-oxo-1,2,3,4-tetrahydroquinolin-3-yl)-benzenesulfonamide and N-(1-Benzyl-2-oxo-6-(thiophen-3-yl)-1,2,3,4-tetrahydroquinolin-3-yl)benzenesulfonamide; eating, metabolic, obesity, cognitive, neurological, pain, inflammatory and psychiatric disorders |
| 10/02/2007 | US7276601 Method and preparing fused oxazinones |
| 10/02/2007 | US7276524 Compounds as antumor agents or immunosuppressants |
| 10/02/2007 | US7276510 Viricides; prevent reproduction of human T-Cell lymphocyte virus |
| 10/02/2007 | US7276508 Indole derivatives useful for the treatment of CNS disorders |
| 10/02/2007 | US7276501 6-(4-substituted-anilino)pyrimidine derivatives, method for preparation thereof and antiviral pharmaceutical composition comprising the same |
| 10/02/2007 | US7276499 Sulfur-containing taxanes, specially covalently bonded to a cell binding agent for targeted delivey to specific cell populations |
| 10/02/2007 | US7276348 Using benzodiazepine derivatives to treat and prevent defects in programed cell death, autoimmune, inflammatory and cell proliferative diseases |
| 10/02/2007 | CA2413424C Substituted bicyclic derivatives for the treatment of abnormal cell growth |
| 10/02/2007 | CA2401229C Aryl fused azapolycyclic compounds |
| 10/02/2007 | CA2378613C Selective iglur5 receptor antagonists for the treatment of migraine |
| 10/02/2007 | CA2352520C Process for the preparation of tetrahydrothieno[3,2-c]pyridine derivatives |
| 10/02/2007 | CA2160912C 3-(het)arylcarboxylic acid derivatives, their preparation and intermediates for their preparation |
| 09/27/2007 | WO2007109459A2 Pyridines and pyridine n-oxides as modulators of thrombin |
| 09/27/2007 | WO2007109334A2 Sip receptor modulating compounds and use thereof |
| 09/27/2007 | WO2007109238A1 Heterocyclic substituted pyridine compounds with cxcr3 antagonist activity |
| 09/27/2007 | WO2007108403A1 Quinoxaline derivative, and light-emitting element, light-emitting device, electronic device using the quinoxaline derivative |
| 09/27/2007 | WO2007107965A1 Cyclohexyl or piperidinyl carboxamide antibiotic derivatives |
| 09/27/2007 | WO2007107539A1 Compounds which potentiate ampa receptor and uses thereof in medicine |
| 09/27/2007 | WO2007107470A2 Pyrazoles as 11-beta-hsd-1 |
| 09/27/2007 | WO2007107352A1 Agents that disrupt cellular replication and their use in inhibiting pathological conditions |
| 09/27/2007 | WO2007085833A3 Pyrimidine derivatives |
| 09/27/2007 | WO2007025009A3 Indenoisoquinolinone analogs and methods of use thereof |
| 09/27/2007 | WO2007022241A3 Novel high affinity quinoline-based kinase ligands |
| 09/27/2007 | US20070225503 Ambient-temperature molten salts and process for producing the same |
| 09/27/2007 | US20070225495 N4-(2,2-Dimethyl-3-oxo-4H-5-pyrid[1,4]oxazin-6-yl)-N2-(3-chloro-4-methoxyphenyl)-5-fluoro-2,4-pyrimidinediamine; signal transduction cascade inhibitor; Fc receptors for IgE (Fc epsilon RI) and IgG (Fc gamma RI) antagonist; autoimmune diseases, antiinflammatory agent; rheumatoid arthritis |
| 09/27/2007 | US20070225372 Amides as Bace Inhibitors |
| 09/27/2007 | US20070225352 methyl-[3-(2-nitro-phenylsulfanyl)-1-pyridin-2-ylmethyl-1H-indol-6-yl]-amine, possessing androgenic activity are useful in androgen-related treatments such as male hypogonadism, male and female hormone replacement therapy and male contraception |
| 09/27/2007 | US20070225336 Anthropodicidal anthranilamides |
| 09/27/2007 | US20070225332 Novel acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndrome |
| 09/27/2007 | US20070225329 Aryl aniline beta2 adrenergic receptor agonists |
| 09/27/2007 | US20070225321 2,4-pyrimidinediamine compounds and their uses |
| 09/27/2007 | US20070225308 2-Amino Quinazoline Derivative |
| 09/27/2007 | US20070225307 C-met modulators and method of use |
| 09/27/2007 | US20070225297 Deuterated hepatitis C protease inhibitors |
| 09/27/2007 | US20070225284 Inhibitors of soluble adenylate cyclase |
| 09/27/2007 | US20070225283 Conformationally restricted urea inhibitors of soluble epoxide hydrolase |
| 09/27/2007 | US20070225282 thrombin inhibitors such as 3-cyano-6-(2,2-difluoro-2-phenyl-ethylamino)-2-{2-[(aminoiminomethyl)aminooxy]ethyl}aminocarbonylmethyl-pyridine-1-oxide, used for the prophylaxis or treatment of diseases and conditions related to thrombin activity in mammals |
| 09/27/2007 | US20070225276 7-Phenylsulfonyl-Tetrahydro-3-Benzazepine Dervatives as Antipsychotic Agents |
| 09/27/2007 | US20070225272 CGRP receptor antagonists |
| 09/27/2007 | US20070225269 Use of (3-(1-(3-Phenyl-Propenyl)-Piperidin-4-Yl)-2,3-Dihydro-Indol-1-Yl)-(Pyridin-4-Yl)-Methanonone Derivatives and Related Compounds as Insecticides |
| 09/27/2007 | US20070225267 beta -secretase inhibitors such as N-{(1S,2S)-1-(3,5-Difluorobenzyl)-2-[(3R,5S,6R)-6-(2,2-dimethylpropoxy)-5-methylmorpholin-3-yl]-2-hydroxyethyl}-acetamide, used for the treatment of neurodegenerative disorders such as Alzheimer's disease |
| 09/27/2007 | CA2679980A1 S1p receptor modulating compounds and use thereof |
| 09/27/2007 | CA2646958A1 Heterocyclic substituted pyridine compounds with cxcr3 antagonist activity |
| 09/27/2007 | CA2646585A1 Compounds which potentiate ampa receptor and uses thereof in medicine |
| 09/27/2007 | CA2646541A1 Agents that disrupt cellular replication and their use in inhibiting pathological conditions |
| 09/27/2007 | CA2645867A1 Substituted gamma lactams as prostaglandin ep2 agonists |
| 09/26/2007 | EP1836198A1 Substituted pyrrolidinones having an antithrombotic effect, the production thereof and their use as medicaments |
| 09/26/2007 | EP1836196A1 Tricyclic delta-opioid modulators |
| 09/26/2007 | EP1836189A1 Novel pyridine compounds |
| 09/26/2007 | EP1836188A1 Pyrazole derivatives as that modulate the activity of cdk, gsk and aurora kinases |
| 09/26/2007 | EP1836183A2 Spiro derivatives as lipoxygenase inhibitors |
| 09/26/2007 | EP1836180A2 Sulfonyl pyrrolidines, method for producing the same and their use as drugs |
| 09/26/2007 | EP1836173A2 Anti-inflammatory medicaments |
| 09/26/2007 | EP1836172A1 5-ht7 receptor antagonists |
| 09/26/2007 | EP1836166A2 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 09/26/2007 | EP1836163A2 Pyrrolidine derivatives for the treatment of a disease depending on the activity of renin |
| 09/26/2007 | EP1836149A1 Phenylbenzoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic uses thereof |
| 09/26/2007 | EP1559715B1 N-{2-chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl}-n'-(5-methyl-3-isoxazolyl)urea salt in crystalline form |
| 09/26/2007 | EP1406873B1 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 09/26/2007 | EP1380121B1 Process to prepare oxazolidinones |
| 09/26/2007 | CN101044137A 2,4-di(aminophenyl)pyrimidine derivatives as plk inhibitors |
| 09/26/2007 | CN101044121A 4-aminopyrimidine-5-one |
| 09/26/2007 | CN101044113A Substituted indole compounds, their preparation and use in medicaments |
| 09/26/2007 | CN101043887A 2-(aryl)azacyclylmethyl carboxylates, sulfonates, phosphonates, phosphinates and heterocycles as s1p receptor agonists |
| 09/26/2007 | CN101041656A Fluorine carbostyrile-oxazolidinone derivative and composition thereof, preparation method and usage |
| 09/25/2007 | US7273936 A 2-pyridyl derivatives therapeutic agent for treating cancer, glomerulonephritis, diabetic nephropathy, hepatic fibrosis, pulmonary fibrosis, hyperplasia, restenosis, skin disorders |
| 09/25/2007 | US7273882 Aminoacetamide acyl guanidines as β-secretase inhibitors |
| 09/25/2007 | US7273877 5-substituted-4-[(substituted phenyl) amino]-2-pyridone derivatives |
| 09/25/2007 | US7273868 excellent phosphodiesterase V (PDE V) inhibitory activity, and being useful as a remedy for the prophylaxis or treatment of penile erectile dysfunction with few side effects |
| 09/25/2007 | US7273867 Anticaogulants; cardiovascular disorders; Factor x inhibitors; antiinflammatory agents |
| 09/25/2007 | US7273866 2-aryl thiazole derivatives as KCNQ modulators |
| 09/25/2007 | US7273865 Alzheimer's disease; Parkinson's disease; antidepressants |
| 09/25/2007 | US7273857 Fused ring compounds substituted with a 8-azabicyclo[3.2.1]octane(cyclo)alkylene group, including benzothiazolones, e.g., 3-[3-(3-Propyl-8-aza-bicyclo[3.2.1]oct-8-yl)-propyl]-3H-benzothiazol-2-one; highly selective muscarinic agonists, particularly for the M1 and/or M4 receptor subtypes |
| 09/25/2007 | US7273856 Antagonist of tachykinins like neurokinins and drugs |
| 09/25/2007 | CA2547947C Azole derivatives as active superoxide radical inhibitors |
| 09/25/2007 | CA2243317C Novel fused pyrrolecarboxamides; a new class of gaba brain receptor ligands |
| 09/25/2007 | CA2230199C Pyridazin-3-one derivatives, their use as a herbicide, and intermediates for their production |